Save information for later
Sign Up

Learn About Spinocerebellar Ataxia Type 13

View Main Condition: Movement Disorders

What is the definition of Spinocerebellar Ataxia Type 13?
Spinocerebellar ataxia 13 (SCA13) is a rare sub-type of spinocerebellar ataxias (SCA), a group of neurological diseases that causes degeneration of the brain and spinal cord. The age when symptoms begin and the type and severity of symptoms of SCA13 can be different from person to person even in the same family. The childhood forms is often least progressive, but may also include mild to moderate learning problems, taking longer to learn to crawl, walk, or run (delayed development of motor skills), and seizures. The main symptoms of SCA13 include difficulties coordinating movements (ataxia), especially walking; abnormal eye movements (nystagmus); mild to moderate intellectual disability; and involuntary muscle jerks or twitches (myoclonic jerks). Other symptoms may include speech difficulty (dysarthria), difficulty eating (dysphagia), slowness of movements (bradykinesia), mild bladder problems, stiff and brisk deep tendon reflexes, and loss of the sense of vibration. SCA13 is caused by changess in the KCNC3 gene and it is inherited in an autosomal dominant manner. Since the symptoms of SCA13 can be similar to other types of SCA, genetic testing is used to confirm the diagnosis.
What are the alternative names for Spinocerebellar Ataxia Type 13?
  • Spinocerebellar ataxia 13
  • Autosomal dominant cerebellar ataxia with mental retardation
  • Cerebellar ataxia, autosomal dominant with mental retardation
  • SCA13
  • Spinocerebellar ataxia type 13
Who are the top Spinocerebellar Ataxia Type 13 Local Doctors?
Distinguished in Spinocerebellar Ataxia Type 13
Family Medicine
Distinguished in Spinocerebellar Ataxia Type 13
Family Medicine

William M Handy, MD PC

389 Falls Dr NW, 
Abingdon, VA 
Languages Spoken:
English

. Dr. Handy is rated as a Distinguished provider by MediFind in the treatment of Spinocerebellar Ataxia Type 13. His top areas of expertise are Spinocerebellar Ataxia Type 12, Spinocerebellar Ataxia Type 15, Spinocerebellar Ataxia Type 8, and Spinocerebellar Ataxia Type 10.

Ilia Itin
Distinguished in Spinocerebellar Ataxia Type 13
Neurology
Distinguished in Spinocerebellar Ataxia Type 13
Neurology

Cleveland Clinic Main Campus

9500 Euclid Avenue, 
Cleveland, OH 
Experience:
32+ years
Languages Spoken:
English, Russian
Offers Telehealth

Ilia Itin is a Neurologist in Cleveland, Ohio. Dr. Itin has been practicing medicine for over 32 years and is rated as a Distinguished provider by MediFind in the treatment of Spinocerebellar Ataxia Type 13. His top areas of expertise are Movement Disorders, Parkinson's Disease, Drug Induced Dyskinesia, and Hereditary Ataxia.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Spinocerebellar Ataxia Type 13
Family Medicine
Distinguished in Spinocerebellar Ataxia Type 13
Family Medicine
1001 Professional Drive, 
Napa, CA 
Languages Spoken:
English
Offers Telehealth

John Dermody is a primary care provider, practicing in Family Medicine in Napa, California. Dr. Dermody is rated as a Distinguished provider by MediFind in the treatment of Spinocerebellar Ataxia Type 13. His top areas of expertise are Osteoarthritis, Spinocerebellar Ataxia Type 4, Spinocerebellar Ataxia Type 8, Advanced Bronchoscopy, and Endoscopy.

What are the latest Spinocerebellar Ataxia Type 13 Clinical Trials?
Coordination of Rare Diseases at Sanford

Summary: CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, in...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center